Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Inhibition of endogenous MHC class II-restricted antigen presentation by tacrolimus (FK506) via FKBP51.

Imai A, Sahara H, Tamura Y, Jimbow K, Saito T, Ezoe K, Yotsuyanagi T, Sato N.

Eur J Immunol. 2007 Jul;37(7):1730-8.

2.

Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells.

Lee YR, Yang IH, Lee YH, Im SA, Song S, Li H, Han K, Kim K, Eo SK, Lee CK.

Blood. 2005 May 15;105(10):3951-5. Epub 2005 Jan 18.

4.

Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.

Han S, Kim K, Song Y, Kim H, Kwon J, Lee YH, Lee CK, Lee SJ, Ha N, Kim K.

Arch Pharm Res. 2008 Mar;31(3):370-6. doi: 10.1007/s12272-001-1166-9. Epub 2008 Apr 13.

PMID:
18409052
5.

Calcineurin inhibitors block MHC-restricted antigen presentation in vivo.

Lee YH, Lee YR, Im SA, Park SI, Kim KH, Gerelchuluun T, Song S, Kim K, Lee CK.

J Immunol. 2007 Nov 1;179(9):5711-6.

6.
7.

Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells.

Cho CS, Chang Z, Elkahwaji J, Scheunemann TL, Manthei ER, Colburn M, Knechtle SJ, Hamawy MM.

Int Immunol. 2003 Nov;15(11):1369-78.

PMID:
14565935
8.

Calcium- and FK506-independent interaction between the immunophilin FKBP51 and calcineurin.

Li TK, Baksh S, Cristillo AD, Bierer BE.

J Cell Biochem. 2002;84(3):460-71.

PMID:
11813252
9.

Protein kinase C delta stimulates antigen presentation by Class II MHC in murine dendritic cells.

Majewski M, Bose TO, Sillé FC, Pollington AM, Fiebiger E, Boes M.

Int Immunol. 2007 Jun;19(6):719-32. Epub 2007 Apr 19.

PMID:
17446207
10.

FKBP12 is the only FK506 binding protein mediating T-cell inhibition by the immunosuppressant FK506.

Xu X, Su B, Barndt RJ, Chen H, Xin H, Yan G, Chen L, Cheng D, Heitman J, Zhuang Y, Fleischer S, Shou W.

Transplantation. 2002 Jun 15;73(11):1835-8.

PMID:
12085010
11.

Comparative analysis of calcineurin inhibition by complexes of immunosuppressive drugs with human FK506 binding proteins.

Weiwad M, Edlich F, Kilka S, Erdmann F, Jarczowski F, Dorn M, Moutty MC, Fischer G.

Biochemistry. 2006 Dec 26;45(51):15776-84. Epub 2006 Dec 19.

PMID:
17176100
12.

Evaluation for synergistic suppression of T cell responses to minor histocompatibility antigens by chloroquine in combination with tacrolimus and a rapamycin derivative, SDZ-RAD.

Hsiao CC, Su WN, Forooghian F, Bader S, Rempel J, HayGlass KT, Gilman A, Schultz KR.

Bone Marrow Transplant. 2002 Dec;30(12):905-13.

13.

Cilomilast, tacrolimus and rapamycin modulate dendritic cell function in the elicitation phase of allergic contact dermatitis.

Bäumer W, Sülzle B, Weigt H, De Vries VC, Hecht M, Tschernig T, Kietzmann M.

Br J Dermatol. 2005 Jul;153(1):136-44.

PMID:
16029339
14.

Calmodulin kinase II regulates the maturation and antigen presentation of human dendritic cells.

Herrmann TL, Morita CT, Lee K, Kusner DJ.

J Leukoc Biol. 2005 Dec;78(6):1397-407. Epub 2005 Oct 4.

PMID:
16204647
15.

Dentritic cell derived IL-18 production is inhibited by rapamycin and sanglifehrin A, but not cyclosporine A.

Ko H, Hambly BD, Eris JM, Levidiotis V, Wyburn K, Wu H, Chadban SJ, Yin JL.

Transpl Immunol. 2008 Nov;20(1-2):99-105. doi: 10.1016/j.trim.2008.07.001. Epub 2008 Jul 26.

PMID:
18662782
16.

Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506).

Panhans-Gross A, Novak N, Kraft S, Bieber T.

J Allergy Clin Immunol. 2001 Feb;107(2):345-52.

PMID:
11174203
17.

FK506 induces chondrogenic differentiation of clonal mouse embryonic carcinoma cells, ATDC5.

Nishigaki F, Sakuma S, Ogawa T, Miyata S, Ohkubo T, Goto T.

Eur J Pharmacol. 2002 Feb 22;437(3):123-8.

PMID:
11890899
18.

EpsinR, a target for pyrenocine B, role in endogenous MHC-II-restricted antigen presentation.

Shishido T, Hachisuka M, Ryuzaki K, Miura Y, Tanabe A, Tamura Y, Kusayanagi T, Takeuchi T, Kamisuki S, Sugawara F, Sahara H.

Eur J Immunol. 2014 Nov;44(11):3220-31. doi: 10.1002/eji.201444475. Epub 2014 Oct 30.

19.

Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens.

Young LJ, Wilson NS, Schnorrer P, Mount A, Lundie RJ, La Gruta NL, Crabb BS, Belz GT, Heath WR, Villadangos JA.

Proc Natl Acad Sci U S A. 2007 Nov 6;104(45):17753-8. Epub 2007 Oct 31.

20.

Supplemental Content

Support Center